Literature DB >> 8943338

Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene.

P Lécine1, M Algarté, P Rameil, C Beadling, P Bucher, M Nabholz, J Imbert.   

Abstract

The interleukin 2 receptor alpha-chain (IL-2R alpha) gene is a key regulator of lymphocyte proliferation. IL-2R alpha is rapidly and potently induced in T cells in response to mitogenic stimuli. Interleukin 2 (IL-2) stimulates IL-2R alpha. transcription, thereby amplifying expression of its own high-affinity receptor. IL-2R alpha transcription is at least in part controlled by two positive regulatory regions, PRRI and PRRII. PRRI is an inducible proximal enhancer, located between nucleotides -276 and -244, which contains NF-kappaB and SRE/CArG motifs. PRRII is a T-cell-specific enhancer, located between nucleotides -137 and -64, which binds the T-cell-specific Ets protein Elf-1 and HMG-I(Y) proteins. However, none of these proximal regions account for the induction of IL-2R alpha transcription by IL-2. To find new regulatory regions of the IL-2R alpha gene, 8.5 kb of the 5' end noncoding sequence of the IL-2R alpha gene have been sequenced. We identified an 86-nucleotide fragment that is 90% identical to the recently characterized murine IL-2-responsive element (mIL-2rE). This putative human IL-2rE, designated PRRIII, confers IL-2 responsiveness on a heterologous promoter. PRRIII contains a Stat protein binding site that overlaps with an EBS motif (GASd/EBSd). These are essential for IL-2 inducibility of PRRIII/CAT reporter constructs. IL-2 induced the binding of Stat5a and b proteins to the human GASd element. To confirm the physiological relevance of these findings, we carried out in vivo footprinting experiments which showed that stimulation of IL-2R alpha expression correlated with occupancy of the GASd element. Our data demonstrate a major role of the GASd/EBSd element in IL-2R alpha regulation and suggest that the T-cell-specific Elf-1 factor can serve as a transcriptional repressor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943338      PMCID: PMC231686          DOI: 10.1128/MCB.16.12.6829

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

1.  Stat3 and Stat4: members of the family of signal transducers and activators of transcription.

Authors:  Z Zhong; Z Wen; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

2.  Elf-1 binds to a critical element in a second CD4 enhancer.

Authors:  A L Wurster; G Siu; J M Leiden; S M Hedrick
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

3.  Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.

Authors:  F X Pimentel-Muiños; M A Muñoz-Fernández; M Fresno
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

4.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.

Authors:  S M Russell; J A Johnston; M Noguchi; M Kawamura; C M Bacon; M Friedmann; M Berg; D W McVicar; B A Witthuhn; O Silvennoinen
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

5.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

Authors:  J A Johnston; M Kawamura; R A Kirken; Y Q Chen; T B Blake; K Shibuya; J R Ortaldo; D W McVicar; J J O'Shea
Journal:  Nature       Date:  1994-07-14       Impact factor: 49.962

6.  Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.

Authors:  B A Witthuhn; O Silvennoinen; O Miura; K S Lai; C Cwik; E T Liu; J N Ihle
Journal:  Nature       Date:  1994-07-14       Impact factor: 49.962

7.  Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase.

Authors:  R A Kirken; H Rui; M G Malabarba; W L Farrar
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

8.  Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation.

Authors:  K Yamamoto; F W Quelle; W E Thierfelder; B L Kreider; D J Gilbert; N A Jenkins; N G Copeland; O Silvennoinen; J N Ihle
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

9.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.

Authors:  H Wakao; F Gouilleux; B Groner
Journal:  EMBO J       Date:  1994-05-01       Impact factor: 11.598

10.  Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

Authors:  J G Giri; M Ahdieh; J Eisenman; K Shanebeck; K Grabstein; S Kumaki; A Namen; L S Park; D Cosman; D Anderson
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  26 in total

1.  A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.

Authors:  D Wang; R Moriggl; D Stravopodis; N Carpino; J C Marine; S Teglund; J Feng; J N Ihle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.

Authors:  John N Allan; Gail J Roboz; Gulce Askin; Ellen Ritchie; Joseph Scandura; Paul Christos; Duane C Hassane; Monica L Guzman
Journal:  Leuk Lymphoma       Date:  2017-07-18

Review 3.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

4.  Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells.

Authors:  S M Foskett; R Ghose; D N Tang; D E Lewis; A P Rice
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Dynamic demethylation of the IL2RA promoter during in vitro CD4+ T cell activation in association with IL2RA expression.

Authors:  Marie-Pierre Belot; Anne-Laure Castell; Sophie Le Fur; Pierre Bougnères
Journal:  Epigenetics       Date:  2018-08-10       Impact factor: 4.528

6.  Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus.

Authors:  J H Yeh; P Lecine; J A Nunes; S Spicuglia; P Ferrier; D Olive; J Imbert
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.

Authors:  Thao P Nguyen; Doug A Bazdar; Joseph C Mudd; Michael M Lederman; Clifford V Harding; Gareth A Hardy; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2015-03-17       Impact factor: 4.962

8.  STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus.

Authors:  Peng Li; Suman Mitra; Rosanne Spolski; Jangsuk Oh; Wei Liao; Zhonghui Tang; Fei Mo; Xingwang Li; Erin E West; Daniel Gromer; Jian-Xin Lin; Chengyu Liu; Yijun Ruan; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-24       Impact factor: 11.205

Review 9.  Recent advances in the understanding of interleukin-2 signal transduction.

Authors:  F Gesbert; M Delespine-Carmagnat; J Bertoglio
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

10.  MER41 repeat sequences contain inducible STAT1 binding sites.

Authors:  Christoph D Schmid; Philipp Bucher
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.